GLP-1 Receptor Agonists and Serious Adverse Events: Separating Established Risks from Uncertain Safety Signals
Published in the Journal of Internal Medicine, a comprehensive review of glucagon-like peptide-1 receptor agonists separates established medical risks—such as gallbladder disease—from uncertain safety signals like thyroid cancer and suicidal … Read More